Cleared Traditional

K902187 - POLARON

K902187 is an FDA 510(k) clearance for POLARON, manufactured by Nurion Industries. The device is a Class 1 Ophthalmic device with product code HPG cleared through the Traditional 510(k) pathway after a 86-day FDA review.

K902187 · Nurion Industries · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1990
Decision
86d
Days
Class 1
Risk

K902187 is an FDA 510(k) clearance for the POLARON. Classified as Aid, Vision, Electronic, Battery-powered (product code HPG), Class I - General Controls.

Submitted by Nurion Industries (Paoli, US). The FDA issued a Cleared decision on August 8, 1990 after a review of 86 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.5900 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Nurion Industries devices

FDA 510(k) Submission Details - K902187

510(k) Number K902187 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 14, 1990
Decision Date August 08, 1990
Days to Decision 86 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
24d faster than avg
Panel avg: 110d · This submission: 86d
Pathway characteristics
Predicate-based equivalence.

HPG Device Classification - Class 1, General Controls

Product Code HPG Aid, Vision, Electronic, Battery-powered
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 886.5900
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.